Home » NJ Biotech Firm Secures Funding for Heart Pump’s Trials
NJ Biotech Firm Secures Funding for Heart Pump’s Trials
CircuLite Inc., a Saddle Brook firm developing the world’s smallest implantable blood pump, expects to get regulatory approval from the Food and Drug Administration by the end of this year for safety trials as it prepares for a U.S. launch in 2013.
NJBIZ
NJBIZ
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May